CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction

SUMMARY: BACKGROUND: Development and validation of a quantitative radiomic risk score (QuRiS) and associated nomogram (QuRNom) for early-stage non-small cell lung cancer (ES-NSCLC) that is prognostic of disease-free survival (DFS) and predictive of the added benefit of adjuvant chemotherapy (ACT) fo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Lancet Digit Health
Главные авторы: Vaidya, Pranjal, Bera, Kaustav, Gupta, Amit, Wang, Xiangxue, Corredor, Germán, Fu, Pingfu, Beig, Niha, Prasanna, Prateek, Patil, Pradnya, Velu, Priya, Rajiah, Prabhakar, Gilkeson, Robert, Feldman, Michael, Choi, Humberto, Velcheti, Vamsidhar, Madabhushi, Anant
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051021/
https://ncbi.nlm.nih.gov/pubmed/32123864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/s2589-7500(20)30002-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы